Effect of Dexmedetomidine and Esketamine on Catheter-related Bladder Discomfort

PHASE4RecruitingINTERVENTIONAL
Enrollment

1,740

Participants

Timeline

Start Date

June 6, 2024

Primary Completion Date

April 30, 2027

Study Completion Date

May 31, 2027

Conditions
Urinary CatheterCatheter-related Bladder DiscomfortDexmedetomidineEsketamine
Interventions
DRUG

Normal saline

20 ml of normal saline is infused intravenously at 80 ml/h after anesthesia induction but before surgery.

DRUG

Dexmedetomidine

Dexmedetomidine 0.5 μg/kg, diluted with normal salinet o 20 ml, is infused intravenously at 60 ml/h after anesthesia induction but before surgery.

DRUG

Esketamine

Esketamine 0.25 mg/kg, diluted with normal saline to 20 ml, is infused intravenously at 80 ml/h after anesthesia induction but before surgery.

DRUG

Combined dexmedetomidine-esketamine

Dexmedetomidine 0.5 μg/kg and esketamine 0.25 mg/kg, diluted with normal saline to 20 ml, is infused intravenously at 80 ml/h after anesthesia induction but before surgery.

Trial Locations (2)

100034

RECRUITING

Peking University First Hospital, Beijing

518036

RECRUITING

Peking University Shenzhen Hospital, Shenzhen

All Listed Sponsors
collaborator

Peking University Shenzhen Hospital

OTHER

lead

Peking University First Hospital

OTHER